Introduction
The most prominent neuroendocrine system for host defense against diseases and stress is activation of the hypothalamic-pituitary-adrenal gland (HPA) axis, resulting in the release of adrenocorticotropic hormone and glucocorticoids. Cytokines are the most potent regulators of the HPA axis [1, 2] . In addition to this axis, catecholamine (CA) release from adrenal medulla also forms an important mechanism for host defense against diseases and stress. The secretory response of CA in adrenal medullary chromaffin cells comes under central control via the splanchnic nerve. It receives peripheral regulation (such as autoregulation) by various factors which are co-released with CA from chromaffin cells, and circular regulation by factors in the blood which increase or decrease in response to diseases and stress [3] . Cytokines are induced in circulation under some conditions, including severe trauma and fever [4] [5] [6] [7] [8] [9] . Interleukin (IL)-1α has been localized immunohistochemically to peripheral neurons with a distribution pattern similar to that of noradrenergic fibers [10, 11] and in rat adrenal medulla where its expression is altered by physiological stimulation of adrenomedullary chromaffin cells [12] . Induction of IL-1 like substances in PC 12 cells by NGF [13] and induction of IL-1α mRNA by various stimulations in bovine adrenal chromaffin cells [14] and in PC 12 cells [15] , and the release of IL-1 form bovine adrenal chromaffin cells [16] have been reported. These results suggest that cytokines may play a physiological role in adrenal medullary functions. In support of this idea, cytokines have been shown to differentially regulate neuropeptide biosynthesis in bovine adrenal chromaffin cells [17] . Furthermore, Yanagihara et al. [18] reported that long-time exposure of bovine adrenal chromaffin cells with IL-1β increased CA release from the cells. Therefore, it is assumed that cytokines directly regulate the process leading to the exocytotic release of CA from adrenomedullary chromaffin cells. To address this issue, we examined the effect of cytokines on intracellular Ca 2+ dynamics and CA release in adrenal medullary chromaffin cells. It was found that IL-1 produced a significant inhibitory effect on stimulation-induced increase in intracellular free Ca 2+ concentration ([Ca 2+ ]i) and release of CA by selectively inhibiting voltage-dependent P/Q-type Ca 2+ channels.
Materials and methods

Materials
The drugs used were recombinant human IL-1α, human IL-1β, human IL-1RA, (R&D systems Inc., Minneapolis, MN, USA); bradykinin, ω-agatoxin IVA, ω-conotoxin GVIA and ω-conotoxin MVIIC (Peptide Institute Inc., Osaka, Japan); caffeine, digitonin, 
Cell preparation and culture
Chromaffin cells of bovine adrenal glands were isolated enzymatically according to the procedure described by [19] , with some modifications [20, 21] . Cells were maintained in Dulbecco's modified Eagle's medium containing 10 % fetal calf serum, penicillin G 100 units/ml, streptomycin 100 µg/ml, ascorbate 0. ]i, cells were incubated at 32 °C with 1 µM fura-2 AM for 30 min in order to load the dye. Cells were then centrifuged at 15 g for 10 min and resuspended to yield 3 x 10 6 cells/ml. Fluorescence was measured using a dual wavelength, fluorescence spectrophotometric mode, with an excitation of 340 and 380 nm, and an emission of 510 nm as described previously [22] . [Ca 2+ ]i was calculated from the fluorescent ratio at 340 and 380 nm, using the equation of Grynkiewikcz et al. [23] and a value of 224 nM for the Kd of fura-2.
Measurement of catecholamine (CA) release
To measure CA release from permeabilized chromaffin cells, cells in monolayer culture were permeabilized with 10 µM of digitonin in a Ca 2+ -free KGP-solution (150 mM gultamate potassium salt, 10 mM PIPES, 5 mM nitrilotriacetic acid, 4.5 mM magnesium acetate, pH 7.0) containing 5 mM Mg-ATP, 0.5 mM EGTA and 0.1 % BSA as described previously [22] . Cells were then incubated for 20 min with KGP-solution containing various amounts of calcium chloride to yield the indicated free Ca 2+ concentrations. After the incubation, the medium was immediately separated from the cells, then perchloric acid was added (5 % of final concentration) and the mixture was centrifuged at 4,500 g for 15 min. IL-1s were added 40 min before the permeabilization with digitonin.
CA release from intact cultured bovine chromaffin cells was performed as previously described [20, 21] . Cultured bovine adrenal chromaffin cells were incubated for 30 min with or without 100 pg/ml IL-1α. The medium was replaced with fresh medium containing IL-1α and ACh, excess KCl at the concentrations indicated, then further incubated for 9 min at 37 °C. The total CA content of the clear supernatant was measured fluorometrically by the method of von Eular and Lishajko [24] with adrenaline as a standard. Values were represented as net increase in CA release (stimulated release -corresponding basal release).
The determination of the ratio of NE/(NE + E) in the medium was performed using HPLC-ED as previously described Sakuma et al. [25] .
Statistics
All experiments were carried out in triplicate, and each experiment was repeated at least 3 times. Data obtained are expressed as mean ± SEM. Statistical significance between means for comparison of two variables was estimated using the Student's t-test. P<0.05
was considered statistically significant. [26, 27] . IL-1α reduced veratridine-induced CA release but this effect was lost in the presence of diltiazem, an inhibitor of VOCC. IL-1α had no effect on Ca shown to increase the production of IP 3 and increase Ca 2+ mobilization from IP 3 -sensitive stores in chromaffin cells [29] . Caffeine also mobilizes Ca 2+ by sensitizing CICR mechanisms [22, [30] [31] [32] . IL-1α had no effect on either bradykinin-or caffeine-induced [Ca 2+ ]i rise in the absence of Ca 2+ in the medium (Fig. 1B-a,b) . Effect of IL-1 on Ca 2+ influx through store-operated Ca 2+ channel (SOC) [28] was also examined (Fig. 1B-c (Fig.1B-c ). 
Results
Inhibition
Inhibition of VOCC by IL-1
In agreement with the restoration of the inhibitory effect of IL-1α on CA release in Ca 2+ -sucrose medium ( ]i rise by diltazem, an inhibitor of VOCC (Fig. 3 ).
Taken together with the disappearance of the inhibitory effect of IL-1α on veratridineinduced CA release in the presence of diltiazem, these findings suggest that VOCC is involved at the site of IL-1α action.
Adrenal chromaffin cells develop several types of VOCC; P/Q type, N-type and L-type.
As VOCC was the suggested site of inhibition for IL-1α by the results presented in Table 1 and Fig. 1 , it is important to determine the type of VOCC that the target for IL-1s. This issue was addressed using specific VOCC inhibitors. (Fig. 3) . Therefore, the remaining [Ca 2+ ]i rise in the presence of nicardipine and ω-conotoxin GVIA could be due to the P/Q-type channel and IL-1α inhibits this channel. Thus, the blockers of the P/Q type channel, ω-agatoxin IVA or ω-conotoxin MVIIC, presented alone or in any combination with other blockers prevented the inhibitory effect of IL-1α on excess KCl-induced [Ca 2+ ]i rise. Similar results were obtained using IL-1β (Fig. 3) , and ACh as a stimulant (data not shown). These results clearly demonstrated that IL-1 inhibited specifically the P/Q type Ca 2+ channel.
In agreement with the effects of these VOCC inhibitors on [Ca 2+ ]i rise, CA release evoked by excess KCl was significantly reduced by ω-agatoxin IVA and ω-conotoxin MVIIC, and more profoundly by nicardipine and nifedipine, but not by ω-conotoxin GVIA (Table 2 Table 2) . IL-1α still produced the inhibitory effect on excess KCl-evoked CA release even in the presence of nicardipine or nifedipine until CA release was profoundly blocked by these inhibitors. Basal CA release in the presence of the drugs tested was not altered by IL-1α
Effects of inhibitors of signaling on IL-1-induced inhibition of [Ca 2+ ]i rise
Although the intracellular signal transduction systems coupled to IL-1 receptors are still uncertain, Plata-Salamán and ffrench-Mullen [33] reported that the depression of Ca of Gi/Go protein coupled pathway, pertussis toxin (PTX) had no effect on the inhibitory effect of IL-1 (Table 3) .
Discussion
Intraventricular injections of cytokines transiently increase blood CA [34] . Yanagihara et al. [18] reported that when bovine adrenal chomaffin cells were cultured with IL-1 for 24
hrs, a small amount of CA was released into the medium. Another study reported that IL-1 and IL-2 did not stimulate epinephrine release from porcine chromaffin cells [35] . ]i, the effects of specific blokers for L-, N-and P/O-type channels on the effect of IL-1α were examined. The inhibitory effect of IL-1α was abolished in the presence of only the blockers of the P/Q-type channel (ω-agatoxin IVA or ω-conotoxin MVIIC) suggesting that IL-1α specifically inhibits the P/Q-type Ca 2+ channel. It has been demonstrated that Q-type Ca 2+ channels are coupled more tightly to active exocytotic sites than L-type channels [39] .
Actually, inhibitors for P/Q-type, but not N-type VOCC, reduced CA release induced by excess KCl, although the secretory response in adrenal chromaffin cells is predominantly dependent on L-type VOCC. Therefore, the inhibition of P/Q-type VOCC by IL-1s can be reflected in the reduction of CA release. It is interesting to consider the physiological regulation by IL-1 on CA release in human adrenal chromaffin cells where P/Q-type Ca 2+ channels are primarily expressed [40] . Also, P/Q-type channels are developed in brain and motor nerve endings. Several diseases, such as episodic ataxia type2; EA2, familial hemiplegic migraine [41] and spinocerebellar ataxia type 6; SCA6 [42] and Lambert-Eaton
Myasthenia syndrome (LEMS) [43] , are due to disfunction of P/Q-type channels in the brain. Whether or not IL-1 modifies P/Q-type Ca 2+ channels in nervous systems as a physiological and/or pathological state remains to be elucidated but is a matter of keen interest.
One persistent aspect of IL-1 signal transduction is the activation of MAP-kinases, which are very rapid cellular responses, and it represents a point of convergence in intracellular signaling activated by tyrosine kinases, by protein kinase C and A kinase [44] . Significantly different from the corresponding control at * p<0.05, ** p<0.01. Experimental design was similar to those described in table 1. Ca 2+ channel antagonists were pretreated for 3 min before challenge with KCl. Values are the mean ± SEM of the net increase in CA release attained with four samples in a batch. The basal CA release in the presence of drugs tested (basal values were 0.08 ± 0.01;ω-AgTx IVA, 0.09 ± 0.01; ω-CgTx GVIA, 0.09 ± 0.01; ω-CgTx MVIIC, 0.10 ± 0.01; ω-AgTx IVA + ω-CgTx GVIA, 0.09 ± 0.01; nicardipine, 0.09 ± 0.01; nifedipine, 0.1 ± 0.01 μg/10 6 cells, respectively). ). The basal CA release in the presence of drugs tested were not altered by IL-1α Significantly different from the corresponding control at * p<0.01. ω-AgTx IVA, ω-agatoxin IVA; ω-CgTx GVIA, ω-conotoxin GVIA; ω-CgTx MVIIC, ω-conotoxin MVIIC 
